Sparc Technologies Valuation

Is SPN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SPN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SPN's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SPN's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SPN?

Key metric: As SPN is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SPN. This is calculated by dividing SPN's market cap by their current revenue.
What is SPN's PS Ratio?
PS Ratio	11.8x
Sales	AU$1.42m
Market Cap	AU$16.78m

SPN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	10x
Enterprise Value/EBITDA	-3.8x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does SPN's PS Ratio compare to its peers?

The above table shows the PS ratio for SPN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	18.9x
FGR First Graphene	44.9x	n/a	AU$22.1m
ANO Advance ZincTek	4.8x	n/a	AU$47.5m
HZR Hazer Group	24.6x	57.5%	AU$84.0m
CLV Clover	1.3x	11.9%	AU$78.5m
SPN Sparc Technologies	11.8x	49.6%	AU$16.8m

Price-To-Sales vs Peers: SPN is good value based on its Price-To-Sales Ratio (11.8x) compared to the peer average (18.9x).

Price to Sales Ratio vs Industry

How does SPN's PS Ratio compare vs other companies in the AU Chemicals Industry?

14 Companies	Price / Sales	Estimated Growth	Market Cap
ORI Orica	1.2x	4.0%	US$5.72b
IPL Incitec Pivot	1.1x	0.7%	US$3.86b
NUF Nufarm	0.5x	7.6%	US$1.02b
DGL DGL Group	0.3x	8.1%	US$102.00m

14 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: SPN is expensive based on its Price-To-Sales Ratio (11.8x) compared to the Australian Chemicals industry average (4.8x).

Price to Sales Ratio vs Fair Ratio

What is SPN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SPN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	11.8x
Fair PS Ratio	25.6x

Price-To-Sales vs Fair Ratio: SPN is good value based on its Price-To-Sales Ratio (11.8x) compared to the estimated Fair Price-To-Sales Ratio (25.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Incitec Pivot

AU$5.9b

Manufactures and distributes industrial explosives, industrial chemicals, and fertilizers in Australia and the United State.

IPL

AU$3.15

4.8%

10.2%

Capral

AU$160.0m

Manufactures, markets, and distributes fabricated and semi-fabricated aluminum related products in Australia.

CAA

AU$9.19

-2.9%

5.1%

Nufarm

AU$1.6b

Develops, manufactures, and sells crop protection solutions and seed technologies in Europe, the Middle East, Africa, North America, and the Asia Pacific.

NUF

AU$4.07

4.9%

-11.5%